ICU Medical (ICUI) Tops Q3 EPS by 18c, Raises FY14 Guidance

ICU Medical (NASDAQ: ICUI) reported Q3 EPS of $0.66, $0.18 better than the analyst estimate of $0.48. Revenue for the quarter came in at $77.5 million versus the consensus estimate of $73 million.

ICU Medical sees FY2014 EPS of $2.25-$2.33, versus prior guidance of $1.95-$2.15 and the consensus of $2.06. ICU Medical sees FY2014 revenue of $304-307 million, versus prior guidance of $285-300 million and the consensus of $297.40 million.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Microchip Technology completes acquisition of Hailo
• Credo Technology shares rise on analyst support and conference comments